NIPH Clinical Trials Search

Basic Information

Recruitment status
Health condition(s) or Problem(s) studied	Overactive bladder
Date of first enrollment	06/08/2007
Target sample size
Countries of recruitment
Study type	Interventional
Intervention(s)	investigational material(s) Generic name etc : Imidafenacin|KRP-197/ONO-8025 INN of investigational material : Therapeutic category code : 251 Agents affecting urinary organs Dosage and Administration for Investigational material : Oral

Outcome(s)

Primary Outcome	Safety, efficacy
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum	>= 20age old
Age maximum	Not applicable
Gender	Both
Include criteria	Key Inclusion Criteria 1. Men and women >= 20 years old 2. Patients with urgency, urinary frequency and urgency incontinence Key Exclusion Criteria 1. Patients with genuine stress incontinence 2. Patients suffering from complications such as bladder tumor, urinary tract stone and symptomatic urinary tract infection 3. Patients suffering from complications contraindicating the use of antimuscarinic medication 4. Patients with polyuria
Exclude criteria